PMC:7269710 / 20596-21150 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"326","span":{"begin":179,"end":189},"obj":"Species"},{"id":"327","span":{"begin":290,"end":296},"obj":"Chemical"},{"id":"328","span":{"begin":460,"end":469},"obj":"Chemical"},{"id":"329","span":{"begin":489,"end":495},"obj":"Disease"}],"attributes":[{"id":"A326","pred":"tao:has_database_id","subj":"326","obj":"Tax:2697049"},{"id":"A327","pred":"tao:has_database_id","subj":"327","obj":"MESH:D010100"},{"id":"A328","pred":"tao:has_database_id","subj":"328","obj":"MESH:D061466"},{"id":"A329","pred":"tao:has_database_id","subj":"329","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The clinical course was uncomplicated for most individuals, with resolution of symptoms over the first few days. Hospital admission was prolonged because of persistently positive SARS-CoV-2 PCR from nasopharyngeal swab testing (median 6 days, range 3–9). One individual needed supplemental oxygen via nasal prongs and another two developed acute respiratory distress requiring intubation and intensive care. Four individuals received experimental treatment of lopinavir with ritonavir. No deaths were recorded in these three clusters as of March 7, 2020."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T97","span":{"begin":179,"end":187},"obj":"Disease"}],"attributes":[{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The clinical course was uncomplicated for most individuals, with resolution of symptoms over the first few days. Hospital admission was prolonged because of persistently positive SARS-CoV-2 PCR from nasopharyngeal swab testing (median 6 days, range 3–9). One individual needed supplemental oxygen via nasal prongs and another two developed acute respiratory distress requiring intubation and intensive care. Four individuals received experimental treatment of lopinavir with ritonavir. No deaths were recorded in these three clusters as of March 7, 2020."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T169","span":{"begin":219,"end":226},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"The clinical course was uncomplicated for most individuals, with resolution of symptoms over the first few days. Hospital admission was prolonged because of persistently positive SARS-CoV-2 PCR from nasopharyngeal swab testing (median 6 days, range 3–9). One individual needed supplemental oxygen via nasal prongs and another two developed acute respiratory distress requiring intubation and intensive care. Four individuals received experimental treatment of lopinavir with ritonavir. No deaths were recorded in these three clusters as of March 7, 2020."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T26","span":{"begin":290,"end":296},"obj":"Chemical"},{"id":"T27","span":{"begin":460,"end":469},"obj":"Chemical"},{"id":"T28","span":{"begin":475,"end":484},"obj":"Chemical"}],"attributes":[{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"}],"text":"The clinical course was uncomplicated for most individuals, with resolution of symptoms over the first few days. Hospital admission was prolonged because of persistently positive SARS-CoV-2 PCR from nasopharyngeal swab testing (median 6 days, range 3–9). One individual needed supplemental oxygen via nasal prongs and another two developed acute respiratory distress requiring intubation and intensive care. Four individuals received experimental treatment of lopinavir with ritonavir. No deaths were recorded in these three clusters as of March 7, 2020."}

{"project":"LitCovid-sentences","denotations":[{"id":"T198","span":{"begin":0,"end":112},"obj":"Sentence"},{"id":"T199","span":{"begin":113,"end":254},"obj":"Sentence"},{"id":"T200","span":{"begin":255,"end":407},"obj":"Sentence"},{"id":"T201","span":{"begin":408,"end":485},"obj":"Sentence"},{"id":"T202","span":{"begin":486,"end":554},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The clinical course was uncomplicated for most individuals, with resolution of symptoms over the first few days. Hospital admission was prolonged because of persistently positive SARS-CoV-2 PCR from nasopharyngeal swab testing (median 6 days, range 3–9). One individual needed supplemental oxygen via nasal prongs and another two developed acute respiratory distress requiring intubation and intensive care. Four individuals received experimental treatment of lopinavir with ritonavir. No deaths were recorded in these three clusters as of March 7, 2020."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T25","span":{"begin":346,"end":366},"obj":"Phenotype"}],"attributes":[{"id":"A25","pred":"hp_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"The clinical course was uncomplicated for most individuals, with resolution of symptoms over the first few days. Hospital admission was prolonged because of persistently positive SARS-CoV-2 PCR from nasopharyngeal swab testing (median 6 days, range 3–9). One individual needed supplemental oxygen via nasal prongs and another two developed acute respiratory distress requiring intubation and intensive care. Four individuals received experimental treatment of lopinavir with ritonavir. No deaths were recorded in these three clusters as of March 7, 2020."}